Aryna Sabalenka backs WTA mandatory gene testing to keep men out of women's tennis

The Women's Tennis Association (WTA) announced a new policy requiring all female players to undergo a one‑time genetic test for the SRY gene, a marker of male biological development. The testing, which can be done via cheek swab, blood or saliva sample, becomes effective on July 21 and is intended to ensure that biological men cannot compete in women’s events. World No. 1 Aryna Sabalenka publicly endorsed the measure, saying it is essential for fairness because “biologically, men are way stronger than women.” She added that she will gladly submit to the test. Players who test positive will be disqualified from the women’s circuit unless they can prove a recognized Difference of Sexual Development condition; those who refuse testing may face disciplinary action. The policy aligns with recent International Olympic Committee reforms and mirrors testing adopted by World Boxing and World Athletics. Former champion Martina Navratilova also praised the move, calling it a step in the right direction. Sabalenka made the comments at a press conference in Montreal ahead of the Canadian Open, emphasizing her focus on maintaining integrity in the tour.